Sarah Wulhfard

1.0k total citations
18 papers, 792 citations indexed

About

Sarah Wulhfard is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Sarah Wulhfard has authored 18 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Genetics. Recurrent topics in Sarah Wulhfard's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and Virus-based gene therapy research (5 papers). Sarah Wulhfard is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (5 papers) and Virus-based gene therapy research (5 papers). Sarah Wulhfard collaborates with scholars based in Switzerland, Italy and Poland. Sarah Wulhfard's co-authors include Dario Neri, Florian Μ. Wurm, María de Jesús, David L. Hacker, Francesca Pretto, Nadine Pasche, Gaurav Backliwal, Markus Hildinger, Alessandra Villa and Giovanni Pellegrini and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sarah Wulhfard

18 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Wulhfard Switzerland 14 534 360 291 180 179 18 792
Toshio Kudo Japan 19 543 1.0× 425 1.2× 355 1.2× 267 1.5× 57 0.3× 47 955
L. Robson United Kingdom 14 501 0.9× 543 1.5× 212 0.7× 130 0.7× 62 0.3× 16 786
L J Hefta United States 10 399 0.7× 332 0.9× 204 0.7× 121 0.7× 74 0.4× 15 661
Gabriela Nagy‐Davidescu Switzerland 9 371 0.7× 329 0.9× 207 0.7× 60 0.3× 57 0.3× 10 571
Barbara J.M. Booth United States 14 437 0.8× 610 1.7× 202 0.7× 126 0.7× 43 0.2× 21 788
Dahlia M. Besmer United States 11 397 0.7× 80 0.2× 317 1.1× 213 1.2× 93 0.5× 14 679
S Nakagawa Japan 16 404 0.8× 71 0.2× 236 0.8× 320 1.8× 188 1.1× 26 702
Michael Schwenkert Germany 13 265 0.5× 221 0.6× 368 1.3× 422 2.3× 75 0.4× 14 673
Naoko Yamane‐Ohnuki Japan 9 964 1.8× 851 2.4× 134 0.5× 353 2.0× 68 0.4× 9 1.1k
Martina Boshell United Kingdom 7 543 1.0× 264 0.7× 201 0.7× 284 1.6× 55 0.3× 9 772

Countries citing papers authored by Sarah Wulhfard

Since Specialization
Citations

This map shows the geographic impact of Sarah Wulhfard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Wulhfard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Wulhfard more than expected).

Fields of papers citing papers by Sarah Wulhfard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Wulhfard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Wulhfard. The network helps show where Sarah Wulhfard may publish in the future.

Co-authorship network of co-authors of Sarah Wulhfard

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Wulhfard. A scholar is included among the top collaborators of Sarah Wulhfard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Wulhfard. Sarah Wulhfard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Guarino, Salvatore, et al.. (2021). Inference of molecular structure for characterization and improvement of clinical grade immunocytokines. Journal of Structural Biology. 213(1). 107696–107696. 3 indexed citations
2.
Puca, Emanuele, Philipp Probst, Patrizia Murer, et al.. (2019). The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8 + T cell activity and synergizes with immune checkpoint inhibitors. International Journal of Cancer. 146(9). 2518–2530. 40 indexed citations
3.
Cazzamalli, Samuele, Patrizia Murer, Giovanni Pellegrini, et al.. (2018). Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2. Clinical Cancer Research. 24(15). 3656–3667. 64 indexed citations
4.
Luca, Roberto De, Alex Soltermann, Francesca Pretto, et al.. (2017). Potency-matched Dual Cytokine–Antibody Fusion Proteins for Cancer Therapy. Molecular Cancer Therapeutics. 16(11). 2442–2451. 34 indexed citations
5.
Gébleux, Rémy, Sarah Wulhfard, Giulio Casi, & Dario Neri. (2015). Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 14(11). 2606–2612. 49 indexed citations
6.
Matasci, Mattia, et al.. (2014). Reformatting of scFv Antibodies into the scFv-Fc Format and Their Downstream Purification. Methods in molecular biology. 1131. 315–334. 19 indexed citations
7.
Villa, Alessandra, Mattia Matasci, Laura Gualandi, et al.. (2014). A Highly Functional Synthetic Phage Display Library Containing over 40 Billion Human Antibody Clones. PLoS ONE. 9(6). e100000–e100000. 40 indexed citations
9.
Pasche, Nadine, et al.. (2012). The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel. Clinical Cancer Research. 18(15). 4092–4103. 82 indexed citations
10.
Wulhfard, Sarah, et al.. (2012). Selection and characterization of human antibody fragments specific for psoriasin – A cancer associated protein. Biochemical and Biophysical Research Communications. 419(2). 250–255. 2 indexed citations
11.
Hemmerle, Teresa, Sarah Wulhfard, & Dario Neri. (2012). A critical evaluation of the tumor-targeting properties of bispecific antibodies based on quantitative biodistribution data. Protein Engineering Design and Selection. 25(12). 851–854. 18 indexed citations
13.
Pasche, Nadine, Janine Woytschak, Sarah Wulhfard, et al.. (2011). Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7. Journal of Biotechnology. 154(1). 84–92. 54 indexed citations
14.
Wulhfard, Sarah, Lucia Baldi, David L. Hacker, & Florian Μ. Wurm. (2010). Valproic acid enhances recombinant mRNA and protein levels in transiently transfected Chinese hamster ovary cells. Journal of Biotechnology. 148(2-3). 128–132. 60 indexed citations
15.
Wulhfard, Sarah. (2009). Transient Recombinant Protein Expression in Mammalian Cells: the Role of mRNA Level and Stability. 5 indexed citations
17.
Wulhfard, Sarah, Stéphanie Tissot, Sophie Bouchet, et al.. (2008). Mild Hypothermia Improves Transient Gene Expression Yields Several Fold in Chinese Hamster Ovary Cells. Biotechnology Progress. 24(2). 458–465. 87 indexed citations
18.
Müller, Natalie, Madiha Derouazi, Sarah Wulhfard, et al.. (2007). Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems. Biotechnology Letters. 29(5). 703–711. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026